GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.8017 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.8017 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA12, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, GSK3B, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TNKS, TNKS2, XDH |
13.7335 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.9626 |
[BP] GO:0007187 |
None
|
ADORA1, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
10.6848 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP3, GSK3B, HSD11B2, HTR1B, HTR5A, IDO1, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
10.4633 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP3, FABP4, GSK3B, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, MMP2, MMP9, PIK3CA, PPARA, PTGS2 |
9.78922 |
[BP] GO:0097756 |
None
|
ADORA1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
9.3733 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2C |
8.47682 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, PTGS2 |
8.15602 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, XDH |
7.73705 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
7.66779 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
7.66779 |
[BP] GO:0007188 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
7.31245 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP3, FABP4, GSK3B, HSD11B2, HTR1B, HTR5A, IDO1, MMP2, PIK3CA, PPARA, PTGS2 |
7.25209 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
7.15497 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
7.1333 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA12, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, FABP3, FUT7, HTR2B, HTR2C, IDO1, PIK3CA, PPARA, PTGS1, PTGS2, XDH |
7.05732 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB |
6.92776 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.92355 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.92355 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1 |
6.71553 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.70518 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.70238 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.70238 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.70238 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, BCL2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
6.70139 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, BCL2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
6.68674 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.53642 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, HSD11B2, HTR1B, HTR5A, PTGS2 |
6.53642 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA7, CNR1, CNR2, DRD2, HTR1B |
6.49641 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
6.49641 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.47149 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, F3, FABP4, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IDO1, MMP1, MMP2, MMP9, PIK3CA, PPARA, PTGS2, TNKS2 |
6.33721 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
6.26416 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.24687 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, PIK3CA, PIK3CB, PTGS1, PTGS2 |
6.2384 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.06409 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
6.06409 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA7, CNR1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, PIK3CB, PTGS2, TNKS, TNKS2 |
6.04289 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, IDO1, PTGS2 |
5.74547 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1 |
5.73741 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, GSK3B, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IDO1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
5.64712 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 |
5.53588 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.42549 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, F3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, TNKS2, XDH |
5.35385 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, HTR1B, HTR2A, MMP9, PTGS2 |
5.35385 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, ALOX15, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, ESR1, F3, FABP4, GSK3B, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, TNKS, TNKS2, XDH |
5.3491 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, F3, FABP4, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
5.3491 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.33131 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, HTR2C, TNKS, TNKS2 |
5.31097 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, F3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, TNKS2, XDH |
5.26591 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD2, F3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, TNKS2, XDH |
5.25459 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.16661 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
5.16661 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
5.12395 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.12395 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
5.112 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.0846 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA7, CNR1, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 |
5.0846 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
5.03964 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, FABP3, GSK3B, HSD11B2, HTR1B, HTR5A, MMP2, PPARA, PTGS2 |
4.98119 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D |
4.9679 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.95145 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, HTR1A |
4.8521 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FABP3, HTR1A, HTR1B, HTR2A, HTR2B, IDO1, MMP2, MMP9, PTGS1, PTGS2, XDH |
4.80447 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR1B, HTR2A |
4.70442 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DHFR, DRD2, PPARA |
4.69865 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA4, CA7, CA9, DHFR |
4.68963 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IDO1, PPARA, PTGS2 |
4.6579 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, PPARA, PTGS2 |
4.6232 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR2A |
4.52283 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.48125 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
4.4507 |
[BP] GO:0090066 |
None
|
ADORA1, ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.35834 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA4, CA7, CA9 |
4.28954 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CYP1B1, DRD2, F3, HTR2A, HTR2B, HTR2C, HTR6, PIK3CA, PIK3CB, PTGS2, XDH |
4.28954 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, PPARA, PTGS1, PTGS2 |
4.28954 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR1D, HTR2B |
4.28954 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C |
4.26378 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, GSK3B, HSD11B2, HTR1A, HTR2C, IDO1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
4.25554 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.25554 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
4.22996 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, BCL2, CA7, CNR1, DRD1, DRD2, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
4.17227 |
[BP] GO:0007154 |
None
|
ADORA1, BCL2, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
4.13558 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 |
4.10699 |
[BP] GO:0007267 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.04862 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA7, CNR1, DRD1, DRD2, PIK3CB, PTGS2, TNKS, TNKS2 |
4.0228 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, TNKS, TNKS2, XDH |
4.01727 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, BCL2, CA7, CNR1, CYP19A1, DRD1, DRD2, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
4.01655 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1 |
4.01555 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CB, PPARA, PTGS2 |
4.01535 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DHFR, DRD1, DRD2, FABP3, GSK3B, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
4.01185 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2, HTR1B |
4.00124 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, IDO1 |
3.93633 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C, IDO1 |
3.91304 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, IDO1, PPARA, PTGS2, PTPRS |
3.88287 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA, PTGS2 |
3.85794 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, BCL2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, F3, FABP3, GSK3B, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IDO1, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, TNKS, TNKS2, XDH |
3.8252 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.78512 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, DHFR, IDO1, PTGS1, PTGS2 |
3.77881 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DHFR, DRD1, DRD2, FABP3, GSK3B, HSD11B2, HTR1B, MMP2, PPARA, PTGS2 |
3.67837 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CA9, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP4, FUT7, GSK3B, HSD11B1, HTR2A, HTR2B, HTR5A, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, TNKS2 |
3.6485 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.6485 |
[BP] GO:0023052 |
None
|
ADORA1, CNR1, DRD1, DRD2, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.6313 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1 |
3.6313 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, MMP9, PTGS2 |
3.60632 |
[BP] GO:0003012 |
None
|
ADORA1, DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.59866 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
3.59731 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.59648 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, CNR1, CNR2, CYP19A1, DHFR, DRD2, ESR1, F3, FABP4, GSK3B, IDO1, MMP2, PPARA, PTGS2, PTPRS, XDH |
3.58648 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.57358 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, PIK3CA |
3.56449 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.56449 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.49256 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.49256 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C, PPARA, PTGS2 |
3.46987 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.44451 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
3.44451 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1 |
3.41981 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.39291 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, ESR1, F3, HTR1A, HTR1B, HTR2A, HTR2B, MMP2, MMP9, PTGS2 |
3.38129 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, PPARA, PTGS2 |
3.35505 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, BCL2, CA12, CA7, CNR1, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
3.35049 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33687 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2 |
3.33687 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, BCL2, CNR1, CNR2, CSNK2A1, DHFR, DRD1, DRD2, ESR1, F3, FABP4, GSK3B, HTR2A, HTR2B, MMP9, PIK3CA, PIK3CB, PTGS2, TNKS, XDH |
3.30855 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
3.27872 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
3.26821 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A |
3.23044 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
3.22665 |
[BP] GO:0002031 |
None
|
DRD2, HTR1B, HTR2B |
3.2242 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.2242 |
[BP] GO:0006936 |
None
|
DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA |
3.2242 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP3, FABP4, GSK3B, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, MMP9, PIK3CA, PPARA, PTGS2, PTPRS, TNKS, TNKS2, XDH |
3.20197 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, ESR1, FABP4, IDO1, MMP2, PPARA, PTGS2, PTPRS |
3.1795 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGS1, PTGS2 |
3.1795 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.13547 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.10442 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP3, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.10442 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA7, DRD1, DRD2, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
3.08799 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGS2 |
3.08799 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
3.07823 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
3.02984 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, BCL2, CA12, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, XDH |
3.0255 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, GSK3B, HTR2B, IDO1, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
3.01416 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR1B, HTR2A |
2.98947 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, GSK3B, IDO1, MMP1, MMP2, MMP9, PIK3CB, XDH |
2.98947 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, PPARA |
2.9834 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR2C |
2.97407 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.96923 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C |
2.95749 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, GSK3B, HTR1B, MMP2, MMP9, PIK3CA, PTGS2 |
2.9473 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, DHFR, HTR2B |
2.92144 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
2.88931 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.88844 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.88844 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, BCL2, CYP1A1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, MMP2, PPARA, PTGS2 |
2.88838 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, GSK3B, HTR2B, IDO1, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.88731 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, ESR1, FABP3, FABP4, GSK3B, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IDO1, MMP9, PIK3CA, PPARA, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.87601 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.86928 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PPARA, PTGS1, PTGS2 |
2.86524 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, GSK3B, HTR2B, IDO1, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.84364 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR1B, HTR2A |
2.82898 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, DRD2, HTR1A, PTGS2 |
2.80799 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, PTGS2 |
2.78438 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.78438 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.7704 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, F3, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, TNKS, TNKS2 |
2.74892 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, DRD2, HTR1A, HTR2A, HTR2C |
2.73153 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, XDH |
2.73005 |
[BP] GO:0046394 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 |
2.70426 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, PTGS2 |
2.70426 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, GSK3B, HTR1B, MMP2, PIK3CA, PTGS2 |
2.70127 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, XDH |
2.70127 |
[BP] GO:0016053 |
None
|
ALOX15, ALOX5, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 |
2.70111 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.67188 |
[BP] GO:0090407 |
organophosphate biosynthetic process
|
ACHE, ALOX15, CSNK2A1, DHFR, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2 |
2.65346 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, HTR1A |
2.6531 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, BCL2, CNR1, DRD2, GSK3B, HTR1B, HTR2A, MMP9, PTGS2 |
2.64347 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.62292 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2 |
2.61016 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, HTR1B, HTR2B |
2.59578 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, DHFR, HTR2B |
2.59578 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, PPARA, PTPRS |
2.59578 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, HTR2A, HTR2B, HTR2C |
2.5749 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.57253 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, BCL2, CA12, CA7, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, GSK3B, HSD11B1, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IDO1, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.56867 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.56742 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.5647 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, BCL2, CSNK2A1, DRD2, ESR1, F3, GSK3B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.5647 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, DRD2, ESR1, GSK3B, HTR7, PPARA |
2.5647 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.55619 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.55619 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A |
2.53782 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.52072 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.51911 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.51531 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PPARA, PTGS1, PTGS2 |
2.51365 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, ESR1, GSK3B, HTR1B, HTR2A, MMP9, PTGS2, PTPRS, XDH |
2.49839 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, ESR1, GSK3B, HTR1B, HTR2A, MMP9, PTGS2, PTPRS, XDH |
2.48739 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, PIK3CA, PIK3CB |
2.48739 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.48739 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, XDH |
2.48262 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, CNR1, CNR2, CYP19A1, DRD2, IDO1, PTPRS |
2.47666 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2 |
2.47626 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA7, DRD1, DRD2, PTGS2 |
2.47604 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.46533 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, IDO1, PPARA, PTGS1, PTGS2 |
2.4589 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9 |
2.43806 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, GSK3B, MMP9, PPARA, PTGS2, PTPRS, XDH |
2.43107 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.40228 |
[BP] GO:0060402 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.39606 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, PIK3CA, PIK3CB |
2.39606 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA12, CA14, CA4, CA7, CA9, DRD2, FABP3, PPARA |
2.39606 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, ESR1, F3, FABP4, GSK3B, HTR2A, HTR2B, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, TNKS, XDH |
2.39449 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C |
2.39449 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.39449 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.39449 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP4, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, XDH |
2.38707 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2 |
2.38518 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, BCL2, DRD2, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.37827 |
[BP] GO:0016477 |
cell migration
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, MMP1, MMP9, PIK3CA, PIK3CB |
2.37041 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.35338 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.35338 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35338 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.35338 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA7 |
2.35338 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.35338 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35338 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.35338 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, GSK3B, MMP9, PPARA, PTGS2, TNKS |
2.35028 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
BCL2, DRD2, PIK3CA, TNKS2 |
2.35028 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, BCL2, DRD2, ESR1, F3, GSK3B, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.32327 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.31963 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.29919 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.26274 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.26274 |
[BP] GO:1900543 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.26026 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, HTR2C |
2.23938 |
[BP] GO:0045980 |
None
|
DRD2, HTR1B, HTR1E, PPARA |
2.23938 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, ESR1, GSK3B, HSD11B1, HTR5A, MMP9, PIK3CA, PPARA, PTGS2, PTPRS |
2.23451 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, BCL2, DRD1, DRD2, FABP4, HTR2A, HTR2B, HTR2C, MMP9, PIK3CA, PIK3CB, PTGS2, XDH |
2.23236 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.22979 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CSNK2A1, DHFR, DRD1, DRD2, GSK3B, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, XDH |
2.21847 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, CYP19A1, CYP1A2, GSK3B, IDO1, NQO2, XDH |
2.20081 |
[BP] GO:0031214 |
biomineral tissue development
|
ALOX15, ALPL, PPARA, PTGS2 |
2.18305 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.18305 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.18305 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, DRD2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C |
2.1829 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, DHFR, DRD2, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2, XDH |
2.18006 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, HTR1B, HTR1E, HTR2A, PPARA |
2.18006 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, HTR1D, MMP9, PTGS2 |
2.17818 |
[BP] GO:0060401 |
None
|
DRD2, HTR2A, HTR2B, HTR2C |
2.17818 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, HTR1B |
2.17818 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.17818 |
[BP] GO:0099565 |
chemical synaptic transmission, postsynaptic
|
DRD2, GSK3B |
2.17818 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.17818 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.17818 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.17818 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.15591 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX15, CYP1A1, IDO1, PTGS1, PTGS2 |
2.15446 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, GSK3B, TNKS |
2.13993 |
[BP] GO:0009266 |
None
|
ADORA1, HTR1B, HTR2A, HTR2B, PTGS2 |
2.1303 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, HTR1B, HTR1E, HTR2A, PPARA |
2.1303 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.11782 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, PTGS1, PTGS2 |
2.10246 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, HTR1B |
2.08101 |
[BP] GO:0045777 |
None
|
ADORA1, CNR1, HSD11B2 |
2.08101 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.08101 |
[BP] GO:0048870 |
cell motility
|
CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, MMP1, MMP9, PIK3CA, PIK3CB |
2.08101 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, HSD11B2, HTR1B, PTGS2 |
2.07463 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C |
2.07416 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, GSK3B, HTR2A, HTR2B, HTR2C, HTR6, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.06932 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.05428 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, HTR6 |
2.04718 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, MMP9, PTGS2 |
2.0394 |
[BP] GO:0019217 |
None
|
CNR1, FABP3, PPARA, PTGS2 |
2.0394 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.0394 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.0394 |
[BP] GO:0014831 |
None
|
HTR1D, HTR2B |
2.0394 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.0394 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.0394 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.0394 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.0394 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA7, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.03385 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, BCL2, CSNK2A1, DHFR, DRD1, DRD2, GSK3B, HTR2B, HTR2C, PIK3CA, PIK3CB, PTGS2, PTPRS, TNKS, XDH |
2.03385 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, GSK3B, TNKS |
2.02983 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, ALPL, BCL2, CA12, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, FABP3, FABP4, FUT7, GSK3B, HSD17B1, HTR1A, HTR1B, HTR2B, HTR2C, IDO1, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, XDH |
2.02983 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.02685 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B |
2.02685 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, DHFR |
2.0125 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, BCL2, CA12, CA14, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FUT7, GSK3B, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS, TNKS, TNKS2 |
5.56255 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, CA4, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTPRS |
5.42405 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, CA12, CA14, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, GSK3B, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, MMP2, PIK3CA, PIK3CB, PTPRS |
4.62806 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTPRS |
4.39925 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPL, BCL2, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FUT7, HSD11B1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS |
4.34592 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ALOX15, CA4, CA9, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PTGS2, PTPRS |
3.91969 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, TUBB3 |
2.42847 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, TUBB3 |
2.21982 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, HSD11B1, HSD11B2, PTGS1, PTGS2 |
2.07816 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.8017 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
17.8017 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
17.4755 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
17.4755 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.3761 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
15.2695 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
13.9221 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
13.5347 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
11.9292 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, CA12, CA14, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, F3, FABP3, FABP4, GSK3B, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, TUBB3, XDH |
10.9443 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, HSD11B1, HSD11B2, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, XDH |
8.20369 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, CA12, CA14, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, MMP1, MMP2, MMP9, NQO2, PPARA, PTGS1, PTGS2, TNKS, TNKS2, XDH |
7.28669 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA12, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, TNKS, XDH |
6.69173 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA4, CA7, CA9 |
6.44282 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
6.35785 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, HSD11B2, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, XDH |
5.96339 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
5.8497 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS1, PTGS2 |
5.63169 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.53588 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS1, PTGS2 |
5.41455 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.31097 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, CA12, CA14, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, F3, FUT7, GSK3B, HSD11B1, HSD11B2, HSD17B1, IDO1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPRS, TNKS, TNKS2, TUBB3, XDH |
5.15085 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
5.112 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, GSK3B, HTR1B, HTR2A, HTR2B, HTR2C, NQO2, PIK3CA, PIK3CB, PPARA |
5.08815 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.0754 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
5.0754 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.03964 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
4.94194 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, CNR1, CNR2, DRD1, DRD2, ESR1, F3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PPARA |
4.51097 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.25554 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
4.01535 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA4, CA7, CA9 |
3.87918 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
3.74791 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.70497 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, IDO1, PTGS2 |
3.6485 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.46838 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA4, CA7, CA9 |
3.30468 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD11B1, HSD11B2, HSD17B1, XDH |
3.25603 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX15, ALOX5, IDO1, PTGS1, PTGS2 |
2.97407 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.96923 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.96923 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.96923 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.88731 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.57253 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.57253 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.57253 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, CBR1, HSD11B1, HSD11B2, HSD17B1 |
2.49839 |
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA4, CA7, CA9, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, TNKS |
2.45915 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.35338 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.35338 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1 |
2.22275 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.17818 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1 |
2.15591 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, DRD2, ESR1, GSK3B, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IDO1, NQO2, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TUBB3, XDH |
2.0394 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, HSD11B2, HSD17B1 |
2.01497 |